国盛证券：技术进步与政策支持共振 脑机接口迎来商业化曙光

Core Insights - The brain-computer interface (BCI) industry is entering a phase of application popularization driven by technological advancements and policy support [1][2][3] Technological Progress - Significant advancements in underlying technologies such as microelectronics, materials science, chips, neuroscience, and algorithms have laid the foundation for breakthroughs in BCI [1] Policy Support - The National Healthcare Security Administration (NHSA) has initiated pricing projects for BCI technologies, paving the way for clinical application and reimbursement starting July 2025 [2] - In January 2025, Beijing and Shanghai released action plans for BCI development, followed by a detailed implementation opinion from multiple government departments in August 2025 [3] Global Development Trends - Neuralink has sparked a global surge in BCI research, with the first surgery completed in January 2024 and seven patients implanted by June 2025 [4] - Other companies like Apple and Synchron are also advancing BCI technologies, with Apple demonstrating thought-controlled iPad technology for ALS patients [4] Domestic Industry Progress - Domestic companies are rapidly advancing BCI research, with significant milestones achieved in clinical trials, including the first clinical implant by Tsinghua University and Xuanwu Hospital in October 2023 [5] - The first complete paraplegic patient regaining the ability to stand and walk was reported in March 2025, showcasing the potential for commercial applications [5]